Biomarker News and Research

RSS

A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule.

$10.3 million NIH grant to support URI neuroscientist's research on retinal scanning to detect early-stage Alzheimer’s

Jessica Alber, assistant professor of biomedical and pharmaceutical sciences at the George & Anne Ryan Institute for Neuroscience at the University of Rhode Island, is looking to change the way doctors diagnose Alzheimer's disease, a change that could raise new possibilities for treatment.

26 Oct 2022

Researchers set sights on a new therapeutic target for aggressive breast cancer

Researchers at VCU Massey Cancer Center have set their sights on a new therapeutic target for an aggressive form of breast cancer with limited treatment options.

25 Oct 2022

Researchers discover new type of microglia related to stroke in the ischemia/reperfusion injured brain

A research team, affiliated with UNIST has identified a new type of microglia associated with stroke in the ischemia/reperfusion (I/R) injured brain.

24 Oct 2022

Systematic review uncovers new links between the thyroid and the heart

Systematic review of 32 studies with 1.3 million participants uncovers new connections between the thyroid and the heart.

24 Oct 2022

FebriDX point-of-care immunoassay can rapidly determine if an infection is bacterial or viral

Researchers explore whether FebriDx could differentiate between bacteria- and virus-induced immune responses during acute respiratory infection.

23 Oct 2022

Multiple research platforms identify environmental chemical agents that promote intestinal inflammation

Inflammatory bowel disease (IBD), a condition characterized by chronic gastrointestinal inflammation, is becoming increasingly common in industrialized countries.

21 Oct 2022

TDP-43 can be useful biomarker for identifying neuropathological subtypes of frontotemporal dementia

Frontotemporal dementia (FTD) is one of the most common causes of progressive dementia in working-age people.

20 Oct 2022

Licorice root extract shows potential as a COVID-19 treatment

A recent study explores the activity of glycyrrhizin against SARS-CoV-2.

19 Oct 2022

Remnants of ancient viruses in the human genome are active in normal tissues

Remnants of ancient viruses in the human genome are active in healthy tissues as well as diseased ones, limiting their utility as disease biomarkers, according to a study by Aidan Burn at Tufts University in Boston, USA and colleagues, publishing October 18th in the open access journal PLOS Biology.

18 Oct 2022

Researchers develop a powerful computational tool for understanding brain health and disease

A team led by researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, in close collaboration with investigators at Mass General Hospital and Beth Israel Deaconess Medical Center has developed a powerful computational tool for understanding brain health and disease, providing an enhanced way of characterizing the activity of the brain during sleep.

18 Oct 2022

Study reveals how a cell signaling molecule can help oral cancer cells acquire high motility

The process of metastasis is when cancer cells gain motility and spread to other sites of the body. Because this is one of the main causes of cancer-related deaths, researchers have aimed to develop therapeutic strategies that can block metastasis.

18 Oct 2022

The Emerging Field of Gene Therapy with Adeno-Associated Viruses

In this interview, Arnaud Delobel, the R&D and Innovation Director at Quality Assistance talks to NewsMed-LS about the emerging field of gene therapy with adeno-associated viruses (AAV).

From Waters | Wyatt Technology 18 Oct 2022

BU researcher awarded $4.6 million U2C grant to develop innovative lung cancer biomarkers

Lung cancer screening by chest computed tomography (CT) can detect lung cancer earlier and make the disease less deadly; but even among nodules that are at intermediate risk, only a small minority are cancerous.

17 Oct 2022

Fecal immunochemical test and mt-sDNA test are equally effective for colorectal cancer screening

Commercially available noninvasive screening tests for colorectal cancer - a fecal immunochemical test (FIT) and the multi-target stool DNAtest (mt-sDNA; or Cologuard®) - are equally effective for screening patients with early-stage colorectal cancer.

17 Oct 2022

High TNF receptors levels could predict COVID-19 mortality and disease severity

High levels of TNFR might successfully predict the increased severity of COVID-19.

16 Oct 2022

Exploring the use of chest CT-based imaging biomarkers for early-stage COVID-19 screening

In a new study, researchers demonstrated that vasculature-like signals (N) in chest computed tomography (CT) scans could serve as robust imaging biomarkers (IBs) of early-stage COVID-19 screening.

14 Oct 2022

Mic60-low gene signature may be a simple tool to estimate pancreatic cancer risk

The mitochondria is a key energy-producing component of the human cell that plays an important role in cancer cell metabolism.

12 Oct 2022

Study explores cell signaling dysregulation and COVID-19 severity

Researchers assessed the impact of dysregulation in cell signaling events on coronavirus disease 2019 (COVID-19) severity.

12 Oct 2022

Neuropilin 2 identified as a novel regulator of distal colonic smooth muscle motility

Colonic motility disorders, especially problems associated with constipation and diarrhea, are common in adults and children, greatly impacting quality of life.

11 Oct 2022

Light-Seq technology for barcoding and deep-sequencing selected cell populations in tissues

Under the microscope, researchers often observe different cell types organizing themselves in peculiar patterns within tissues, or sometimes a rare cell type that stands out by occupying a unique position, exhibiting an unusual shape, or expressing a specific biomarker molecule.

10 Oct 2022

Biomarker News and Research

Further Reading

$10.3 million NIH grant to support URI neuroscientist's research on retinal scanning to detect early-stage Alzheimer’s

Researchers set sights on a new therapeutic target for aggressive breast cancer

Researchers discover new type of microglia related to stroke in the ischemia/reperfusion injured brain

Systematic review uncovers new links between the thyroid and the heart

FebriDX point-of-care immunoassay can rapidly determine if an infection is bacterial or viral

Multiple research platforms identify environmental chemical agents that promote intestinal inflammation

TDP-43 can be useful biomarker for identifying neuropathological subtypes of frontotemporal dementia

Licorice root extract shows potential as a COVID-19 treatment

Remnants of ancient viruses in the human genome are active in normal tissues

Researchers develop a powerful computational tool for understanding brain health and disease

Study reveals how a cell signaling molecule can help oral cancer cells acquire high motility

The Emerging Field of Gene Therapy with Adeno-Associated Viruses

BU researcher awarded $4.6 million U2C grant to develop innovative lung cancer biomarkers

Fecal immunochemical test and mt-sDNA test are equally effective for colorectal cancer screening

High TNF receptors levels could predict COVID-19 mortality and disease severity

Exploring the use of chest CT-based imaging biomarkers for early-stage COVID-19 screening

Mic60-low gene signature may be a simple tool to estimate pancreatic cancer risk

Study explores cell signaling dysregulation and COVID-19 severity

Neuropilin 2 identified as a novel regulator of distal colonic smooth muscle motility

Light-Seq technology for barcoding and deep-sequencing selected cell populations in tissues

Event guide: 16th Clinical Biomarkers & CDx Summit Europe eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo